Clinical characteristics, treatment patterns, and survival outcomes in ductal prostate cancer: a multicenter retrospective analysis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical Features, Treatment Approaches, and Survival Rates in Ductal Adenocarcinoma of the Prostate: A Retrospective Multicenter Study

  • By

  • A. Handke

  • P. Paffenholz

  • K. Schlack

  • K. E. Seifert

  • J. Linxweiler

  • J. Mink

  • F. Flockerzi

  • T. Nestler

  • M. Wenzel

  • C. Siech

  • C. Darr

  • V. Grünwald

  • F. Roghmann

  • K. H. Tully

  • August 22, 2026

Share

  • 1

    Prostatic ductal adenocarcinoma (PDA) is an aggressive subtype of prostate cancer with poorer prognosis compared to acinar adenocarcinoma.

  • 2

    PDA is often diagnosed at advanced stages, correlating with higher ISUP grades, extraprostatic extension, and positive surgical margins.

  • 3

    Lower serum PSA concentrations in PDA may contribute to underdiagnosis, despite its aggressive nature and high disease-specific mortality.

  • 4

    The study enrolled 82 patients with histologically confirmed PDA from seven urological centers in Germany, focusing on oncologic outcomes.

  • 5

    Overall survival for metastatic PDA is 72% at 5 years, with median survival reaching 77 months, highlighting its serious nature.

Original Source(s)

Clinical characteristics, treatment patterns, and survival outcomes in ductal prostate cancer: a multicenter retrospective analysis

  • by A. Handke, P. Paffenholz, K. Schlack, K. E. Seifert, J. Linxweiler, J. Mink, F. Flockerzi, T. Nestler, M. Wenzel, C. Siech, C. Darr, V. Grünwald, F. Roghmann, K. H. Tully

  • August 22, 2026

Related Content

Updated ASTRO Guideline Reflects a New Era for Radiation Therapy in Pancreatic Cancer

An updated clinical practice guideline from the American Society for Radiation Oncology substantially expands and modernizes recommendations for the use of radiation therapy in pancreatic cancer.

  • by

  • August 14, 2026

  • 6 min
Moving Cancer Survivorship Into Routine Care—Why Are We Still Not Ready for Change?

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer